Get started
Author

Paul Cannell

Observed names: Cannell, P., P Cannell, P K Cannell, P. Cannell, P.K. Cannell, PAUL CANNELL, PAUL K. CANNELL, Paul Cannel, Paul K. Cannell, Paul Kenneth Cannell
Observed institutions: The University of Sydney, The Royal Melbourne Hospital, Australian Red Cross Lifeblood, Royal Prince Alfred Hospital, Royal Perth Hospital, Royal North Shore Hospital, Concord Repatriation General Hospital, Hospital Universitario La Paz, Fiona Stanley Hospital, Government of Western Australia Department of Health, The Royal Free Hospital, Monash Medical Centre, Wollongong Hospital, Westmead Hospital, UNSW Sydney, Ospedale Papa Giovanni XXIII, Prince of Wales Hospital, Essen University Hospital, Calvary Mater Newcastle Hospital, Helios Klinikum Erfurt, Pathwest Laboratory Medicine, Fiona Stanley Fremantle Hospitals Group, Stiftung Universitätsmedizin Essen, Monash University, Ludwig-Maximilians-Universität München
ORCID: 0009-0003-7737-5126
Observed ORCID: 0009-0003-7737-5126
OpenAlex ID: A5113921530
Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety
2018 · Wolfgang Hiddemann, Anna Maria Barbui, et al. · Journal of Clinical Oncology · 241
A pilot randomized trial comparing CD34‐selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis
2002 · John Moore, Peter Brooks, et al. · Arthritis & Rheumatism · 165
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
2004 · John A Snowden, Jakob Passweg, et al. · PubMed · 163
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial
2018 · Judith Trotman, Sally F Barrington, et al. · The Lancet Oncology · 152
PDF
Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study
2011 · Richard Herrmann, Marian Sturm, et al. · International Journal of Hematology · 100
When the safety net of treatment has been removed: Patients’ unmet needs at the completion of treatment for haematological malignancies
2009 · E.A. Lobb, D. Joske, et al. · Patient Education and Counseling · 88
PDF
Allogeneic Hematopoietic Stem Cell Transplantation Recipients Have Defects of Both Switched and IgM Memory B Cells
2009 · Lloyd J. D'Orsogna, Matthew P. Wright, et al. · Transplantation and Cellular Therapy · 81
PDF
Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results
2016 · Simon J. Harrison, Paul Mainwaring, et al. · Clinical Cancer Research · 76
Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response
1997 · L Foroni, LA Coyle, et al. · Leukemia · 73
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
2025 · Michael Wang, Michael Wang, et al. · Journal of Clinical Oncology · 67
Phase 1 Clinical Evaluation of Twice-Weekly Marizomib (NPI-0052), a Novel Proteasome Inhibitor, in Patients with Relapsed/Refractory Multiple Myeloma (MM)
2011 · Paul G. Richardson, Andrew Spencer, et al. · Blood · 64
Unrelated Cord Blood Transplantation for Patients with Primary or Secondary Myelofibrosis
2014 · Marie Robin, Federica Giannotti, et al. · Transplantation and Cellular Therapy · 61
PDF
Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma
2019 · Ivan Spicka, Enrique M. Ocio, et al. · Annals of Hematology · 57
PDF
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
2011 · H. Iland, K. Bradstock, et al. · Haematologica · 57
PDF
Dasatinib therapy for systemic mastocytosis: four cases
2008 · Duncan Purtill, Julian Cooney, et al. · European Journal Of Haematology · 51
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
2018 · Max S. Topp, Zachary Zimmerman, et al. · Blood · 50
Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study
2014 · I A Bilmon, L J Ashton, et al. · Bone Marrow Transplantation · 47
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia
2001 · K Bradstock, J Matthews, et al. · Leukemia · 44
Collection and Recruitment of CD34+ Cells During Large-Volume Leukapheresis
1997 · GAVIN CULL, JOHN IVEY, et al. · Journal of Hematotherapy · 39
The use of IgH fingerprinting and ASO‐dependent PCR for the investigation of residual disease (MRD) in ALL
1996 · James C. S. Chim, Luke A. Coyle, et al. · British Journal of Haematology · 39
A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation
2004 · J Moore, D Ma, et al. · Bone Marrow Transplantation · 37
Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia.
1995 · J O'Reilly, B Meyer, et al. · PubMed · 35
Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study
2016 · Claire M. Vajdic, Eleni Mayson, et al. · Transplantation and Cellular Therapy · 34
Plasma lipids are altered in Gaucher disease: Biochemical markers to evaluate therapeutic intervention
2007 · Peter J. Meikle, Philip D. Whitfield, et al. · Blood Cells Molecules and Diseases · 32
Acute graft-versus-host disease after liver transplant: Novel use of etanercept and the role of tumor necrosis factor α inhibitors
2009 · Lena Thin, Gerry MacQuillan, et al. · Liver Transplantation · 31
PDF
Works count: 131
Citation count: 2,290
H-index: 26
I10-index: 43
Year
Topic
Type